Search hospitals > Maryland > Bethesda
Mid-Atlantic Epilepsy and Sleep Center
Claim this profileBethesda, Maryland 20817
Global Leader in Epilepsy
Conducts research for Lennox Gastaut Syndrome
Conducts research for Postprandial Fullness Syndrome
Conducts research for Seizures
Conducts research for Partial Seizures
50 reported clinical trials
1 medical researcher
Summary
Mid-Atlantic Epilepsy and Sleep Center is a medical facility located in Bethesda, Maryland. This center is recognized for care of Epilepsy, Lennox Gastaut Syndrome, Postprandial Fullness Syndrome, Seizures, Partial Seizures and other specialties. Mid-Atlantic Epilepsy and Sleep Center is involved with conducting 50 clinical trials across 31 conditions. There are 1 research doctors associated with this hospital, such as Pavel Klein.Area of expertise
1Epilepsy
Global Leaderinformed consent
Legally Authorized Representative
TSC1 positive
2Lennox Gastaut Syndrome
Top PIs
Clinical Trials running at Mid-Atlantic Epilepsy and Sleep Center
Epilepsy
Stroke
Partial Seizures
Seizures
Temporal Lobe Epilepsy
Lennox Gastaut Syndrome
Ischemia
Ischemic Stroke
Postprandial Fullness Syndrome
Cenobamate
for Focal Seizures
Cenobamate (YKP3089) is a small molecule approved in the United States (US), Europe and several other countries around the world for the treatment of Partial-Onset (focal) seizures in adult subjects (≥18 years of age). In the US it is approved for use as monotherapy, however, there is little clinical data assessing its use as monotherapy in adults with POS. This study is designed to explore the effectiveness of doses of 100 mg/day and 200 mg/day as monotherapy in adult subjects with newly diagnosed or recurrent POS/focal onset epilepsy.
Recruiting3 awards Phase 41 criteria
Cenobamate
for Epilepsy
Primary objective: To evaluate the safety and tolerability of cenobamate in pediatric subjects 2-17 years of age with partial-onset (focal) seizures
Recruiting2 awards Phase 312 criteria
XEN1101
for Seizures
This trial tests XEN1101, a medication added to current treatments, in people with generalized epilepsy experiencing PGTCS who are already on 1-3 anti-seizure medications. The goal is to see if taking XEN1101 with an evening meal can help reduce seizure frequency.
Recruiting1 award Phase 3
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Mid-Atlantic Epilepsy and Sleep Center?
Mid-Atlantic Epilepsy and Sleep Center is a medical facility located in Bethesda, Maryland. This center is recognized for care of Epilepsy, Lennox Gastaut Syndrome, Postprandial Fullness Syndrome, Seizures, Partial Seizures and other specialties. Mid-Atlantic Epilepsy and Sleep Center is involved with conducting 50 clinical trials across 31 conditions. There are 1 research doctors associated with this hospital, such as Pavel Klein.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.